Shares of Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $16.00.
A number of research analysts have commented on NTHI shares. Roth Capital started coverage on Neonc Technologies in a report on Thursday, September 24th. They issued a “buy” rating on the stock. Weiss Ratings upgraded shares of Neonc Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday. BTIG Research reiterated a “buy” rating and issued a $15.00 price objective on shares of Neonc Technologies in a research note on Tuesday, September 8th. Finally, Wall Street Zen downgraded shares of Neonc Technologies from a “hold” rating to a “sell” rating in a report on Saturday, August 15th.
View Our Latest Research Report on NTHI
Insider Buying and Selling
Institutional Investors Weigh In On Neonc Technologies
A number of large investors have recently bought and sold shares of the company. Global Retirement Partners LLC bought a new position in Neonc Technologies in the 2nd quarter valued at about $126,000. BlackRock Inc. bought a new position in Neonc Technologies in the second quarter valued at approximately $815,000. Westmount Partners LLC increased its stake in Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after acquiring an additional 153,858 shares during the last quarter. Finally, Bank of America Corp DE acquired a new position in Neonc Technologies during the second quarter valued at approximately $1,017,000.
Neonc Technologies Price Performance
NTHI stock opened at $2.53 on Friday. Neonc Technologies has a 1-year low of $2.52 and a 1-year high of $12.10. The business’s 50 day simple moving average is $3.84 and its 200 day simple moving average is $4.55.
Neonc Technologies (NASDAQ:NTHI – Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.46).
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
See Also
- Five stocks we like better than Neonc Technologies
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
